Nootropic peptides represent a fascinating intersection of neuroscience and peptide research. Semax is being investigated for its potential cognitive-enhancing and neuroprotective properties.
A synthetic heptapeptide analog of ACTH(4-7) developed in Russia. Studied for cognitive enhancement, neuroprotection, BDNF upregulation, and post-stroke recovery applications.
Also Known As
ACTH (4-7)-PGP, Semax Acetate
What is Semax?
Semax is classified under the Nootropic category of peptides. A synthetic heptapeptide analog of ACTH(4-7) developed in Russia. Studied for cognitive enhancement, neuroprotection, BDNF upregulation, and post-stroke recovery applications.
Mechanism of Action: A synthetic heptapeptide analog of ACTH(4-10) with a Pro-Gly-Pro C-terminal extension that enhances metabolic stability. It modulates BDNF and NGF expression, affects serotonergic and dopaminergic systems, and exhibits nootropic and neuroprotective properties without hormonal activity.
Cognitive & Neuroprotection Research
Primary Research Areas: Cognitive enhancement, stroke recovery, neuroprotection, ADHD, optic nerve disease, anxiety.
Key Research Findings: Approved in Russia and Ukraine for cognitive disorders and stroke. Studies show increased BDNF expression, improved memory consolidation, and neuroprotection against oxidative stress. Clinical trials in stroke patients showed improved neurological recovery.
Safety Profile & Considerations
Well-tolerated in clinical use in Russia with minimal reported side effects. Not approved by FDA or EMA. Long-term safety data from Western regulatory-standard trials is lacking.
Related Research Topics
Understanding Semax requires familiarity with these related concepts in nootropic research. Each topic represents a broader field that intersects with current peptide research.
References & Further Reading
Ashmarin IP, et al. Neuropeptides in CNS: pharmacological aspects. Neurochem Res. 1999;24:1533-41.
Stay Updated on Peptide Research
Get the latest science-backed articles on peptides delivered to your inbox.